Form 4 for ZNTL Zentalis Pharmaceuticals, Inc.
Accepted 2021-10-04 00:00:00 ET · period of report 2021-10-02 · accession 0001725160-21-000199 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-04 | 2021-10-02 | ZNTL | Epperly Melissa B, | CFO | F - Tax | $67.13 | -17.1K | 250.0K | -6% | -$1.15M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-02 | F | D | 17,080 | $67.13 | 250,002 | D | — | — | (F1) Includes 397 shares acquired under the Zentalis Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan on September 30, 2021. |